eXmoor, the expert cell and gene therapy (CGT) services company, has raised an initial investment of £12m ($17m) from specialist healthcare investment firm MVM Partners to enable eXmoor’s ambitious expansion plans. This will create a new dedicated 50,000 sq ft CGT process development and clinical manufacturing facility in Bristol (UK). eXmoor has expanded rapidly over the last 5 years, developing a portfolio of clients across the UK and internationally, completing over 400 projects across 15 countries to date.